---
title: "Top of the Street: EssilorLuxottica, BPER, UBS, DiaSorin, Lifco and Indutrade"
date: "2025-02-11 22:44:43"
summary: "A round-up of notable broker activity this morning from Europe's top-ranked* analysts:** Jefferies upgrades EssilorLuxottica to \"buy\" from \"hold,\" seeing the Franco-Italian eyewear maker's earnings on the cusp of accelerating thanks to its new growth drivers in AI and medical technology** Citigroup cuts BPER Banca to \"neutral\" from \"buy\" after..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

A round-up of notable broker activity this morning from Europe's top-ranked\* analysts:

\*\* Jefferies upgrades EssilorLuxottica to "buy" from "hold," seeing the Franco-Italian eyewear maker's earnings on the cusp of accelerating thanks to its new growth drivers in AI and medical technology

\*\* Citigroup cuts BPER Banca to "neutral" from "buy" after bid on peer Banca Popolare di Sondrio , the brokerage seeing limited EPS benefits, a larger-than-simulated capital impact and questions on combined ROTE

\*\* Deutsche Bank raises Swiss peer UBS to "buy" from "hold", saying the company continues to deliver strongly on cost cutting and significant capital return increase, remains in the right businesses for 2025 and beyond

INITIATIONS AND REINSTATEMENTS

\*\* DB starts Italian medical diagnostic group DiaSorin with "buy" and PT of EUR 121, cites "XL growth with multiPLEX opportunities", strong profitable growth track record, attractive valuation, upcoming catalysts such as launches and partnerships, expects co to outperform its end markets

\*\* UBS initiates Lifco with rating "buy" and TP of SEK 420, flagging a "quality stock" among Swedish acquirers, expecting co to continue delivering about 9% pa acquired revenues mid-term

\*\* The brokerage also starts coverage on Indutrade with "buy" rating and PT of SEK 400, naming it its value stock among Swedish serial acquirers, pointing to co's acquired revenues of about 7% pa and further margin expansion

(\*Analyst rankings from Thomson Reuters StarMine. The scale is from 1-star to 5-star with 5 being the best. Analysts are ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)

($1 = 0.9695 euros)

[Reuters](https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3P2106:0-top-of-the-street-essilorluxottica-bper-ubs-diasorin-lifco-and-indutrade/)
